Siemens Charts Course Through Share Buybacks and Corporate Restructuring

Siemens AG accelerates its €6B share buyback, raises EPS guidance, and details plans to spin off Siemens Healthineers to shareholders, marking a major corporate transformation.

Siemens AG finds itself at a pivotal moment, simultaneously executing a significant share repurchase initiative and embarking on a historic corporate transformation. While the company's stock has recovered from a six-month low hit in late March, it remains notably below its value at the start of the year.

Financial Performance Fuels Confidence and Forecast Upgrade

The industrial conglomerate's recent financial results provide the foundation for its current strategy. For the first quarter of its fiscal year, Siemens reported an 8% increase in revenue, reaching €19.1 billion. Order intake saw an even stronger surge, climbing 10% year-over-year to €21.4 billion.

Bolstered by this performance, management has raised its full-year earnings per share (EPS) guidance. The new forecast range is €10.70 to €11.10, up from the previous projection of €10.40 to €11.00. This upgraded outlook accompanies an aggressive capital return program.

Accelerated Buyback Program in Focus

The company's share repurchase plan is progressing rapidly. During the week of March 16 to 22, Siemens acquired approximately 711,000 of its own shares. Since the program's commencement in February 2024, the total has surpassed 22 million shares repurchased.

Nearly €4.4 billion of the authorized €6 billion total has already been deployed. Furthermore, the company plans to retire 18 million treasury shares in March, a move that will mechanically increase its earnings per share.

Despite the strong overall figures, regional challenges persist. Revenue in Asia declined by 4%, primarily due to conditions in China. While the United States market showed growth, executives cite volatile tariff policies as a complicating factor for planning.

Major Structural Shift with Healthineers Spinoff

Parallel to the buyback, Siemens is preparing one of the most substantial restructurings in its history. The group intends to distribute roughly 30% of its stake in Siemens Healthineers directly to existing Siemens shareholders. The company has committed to providing a detailed timeline for this transaction early in the second quarter.

A key point for investors is the commitment to maintain the planned dividend of €5.35 per share, which will remain unchanged following the deconsolidation of Healthineers.

All eyes will be on the specifics of the Healthineers separation as Siemens approaches its second-quarter earnings report on May 13, 2026. The terms of this transaction will offer the clearest indication of how the broader corporate overhaul will materialize for the investment community.